J. Díez-Martín

I. Buño, J. Anguita, J. Díez-Martín, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Exome sequencing reveals heterogeneous clonal dynamics in donor cell myeloid neoplasms after stem cell transplantation.

I. Buño, F. Ortuño, A. Balas, 2020, Haematologica.

The Role of Hematopoietic Stem Cell Transplantation for HIV-Associated Lymphomas

J. Berenguer, J. Díez-Martín, P. Balsalobre, 2013 .

Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphoma

J. Anguita, J. Berenguer, J. Díez-Martín, 2020, Bone Marrow Transplantation.

Hematopoietic Stem Cell Transplantation in Patients Infected With HIV

J. Berenguer, J. Díez-Martín, P. Miralles, 2010, Current HIV/AIDS reports.

A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.

M. C. Aguilera-Morillo, J. Romo, R. Lillo, 2018, Blood advances.

Composite Lymphoma Containing Mantle Cell and Peripheral T-cell Lymphoma, Not Otherwise Specified: A Report of 2 Cases Treated With Up-front Autologous Stem Cell Transplantation.

J. Menárguez, J. Díez-Martín, C. Martínez-Laperche, 2019, Applied immunohistochemistry & molecular morphology : AIMM.

The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation

Marcos González, I. Buño, C. Solano, 2015, PloS one.

Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party

A. Ganser, N. Kröger, N. Russell, 2019, Bone Marrow Transplantation.

Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party

S. Montoto, N. Kröger, P. Dreger, 2019, Bone Marrow Transplantation.

Sau3A in situ digestion of human chromosome 3 pericentrometric heterochromatin. I. Differential digestion of alpha-satellite and satellite 1 DNA sequences.

I. Buño, J. Díez-Martín, C. López‐Fernández, 2001, Genome.

Effect of addition of rituximab to salvage chemotherapy on outcome of patients with diffuse large B-cell lymphoma relapsing after an autologous stem-cell transplantation.

E. González-Barca, M. Ramírez, J. de la Rubia, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience

I. Buño, L. Bento, J. Díez-Martín, 2016, Bone Marrow Transplantation.

Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia

G. Dewald, J. Díez-Martín, R. Pierre, 1988, American journal of hematology.

Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party

S. Montoto, J. Sierra, D. Blaise, 2018, British journal of haematology.

RAD 51 and XRCC 3 polymorphism frequency and risk of myelodysplastic syndromes

J. Ribera, J. Díez-Martín, 2008 .

Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation

I. Buño, J. Anguita, L. Bento, 2014, European journal of haematology.

Lymphoma associated chromosomal abnormalities can easily be detected by FISH on tissue imprints. An underused diagnostic alternative

I. Buño, J. Menárguez, J. Díez-Martín, 2004, Journal of Clinical Pathology.

Unusual presentation of extranodal peripheral T‐cell lymphomas with multiple paraneoplastic features

P. Banks, J. Lust, T. Witzig, 1991, Cancer.

Adult celiac disease, small and medium vessel cutaneous necrotizing vasculitis, and T cell lymphoma.

R. Winkelmann, P. Banks, J. Díez-Martín, 1988, Journal of the American Academy of Dermatology.

Hematologic disorders in 13 patients with acquired trisomy 21 and 13 individuals with Down syndrome.

G. Dewald, R. Jenkins, J. Díez-Martín, 2005, American journal of medical genetics. Supplement.

Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study

V. Jiménez‐Yuste, P. Llamas, J. Martínez-López, 2020, Journal of Hematology & Oncology.

Complete RH and Kell matching related to low alloimmunisation risk in sickle cell disease: prevalence and risk factors of alloimmunisation in a Spanish Tertiary Care National Reference Centre.

J. Anguita, J. Díez-Martín, C. Beléndez, 2020, Blood transfusion = Trasfusione del sangue.

Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT

J. Esteve, J. Bourhis, M. Labopin, 2020, Bone Marrow Transplantation.

ST2 and REG3α as Predictive Biomarkers After Haploidentical Stem Cell Transplantation Using Post-transplantation High-Dose Cyclophosphamide

I. Buño, J. Anguita, J. Díez-Martín, 2019, Front. Immunol..

Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia.

M. Labopin, A. Nagler, M. Mohty, 2021, Transplantation and cellular therapy.

Impact of total body irradiation‐ vs chemotherapy‐based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia

M. Labopin, D. Blaise, A. Nagler, 2020, American journal of hematology.

Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia

M. Fernández-Aceñero, J. Díez-Martín, I. Jarque, 2010, Annals of Hematology.

Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.

C. Solano, M. Sanz, S. Brunet, 2003, Experimental hematology.

Mutation of the NPM1 gene contributes to the development of donor cell-derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia.

I. Buño, J. Díez-Martín, C. Martínez-Laperche, 2013, Human pathology.

Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia

R. Fanin, F. Baron, M. Labopin, 2022, Bone Marrow Transplantation.

FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia

I. Buño, J. Anguita, J. Díez-Martín, 2022, Cancers.

Human leukocyte antigen‐haploidentical transplantation for relapsed/refractory acute myeloid leukemia: Better leukemia‐free survival with bone marrow than with peripheral blood stem cells in patients ≥55 years of age

R. Fanin, F. Baron, M. Labopin, 2022 .

Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation

I. Buño, J. Anguita, J. Sanz, 2020, Annals of Hematology.

Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation.

I. Buño, J. Anguita, J. Díez-Martín, 2019, Blood advances.

Busulfan‐based myeloablative conditioning regimens for haploidentical transplantation in high‐risk acute leukemias and myelodysplastic syndromes

I. Buño, L. Bento, J. Díez-Martín, 2018, European journal of haematology.

Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party

M. Labopin, I. Yakoub-Agha, D. Blaise, 2017, Journal of Hematology & Oncology.

Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders.

I. Buño, J. Anguita, J. Díez-Martín, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation.

M. Labopin, D. Farge, A. Vora, 2013, Blood.

Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders.

I. Buño, J. Anguita, J. Díez-Martín, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A second administration of glucarpidase in a different cycle of high-dose methotrexate: Is it safe and effective in adults?

J. Díez-Martín, S. Osorio, E. Landete, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Conventional cytogenetics and FISH evaluation of chimerism after sex-mismatched bone marrow transplantation (BMT) and donor leukocyte infusion (DLI).

I. Buño, P. Llamas, J. Díez-Martín, 1998, Haematologica.

A new case of successful outcome of pregnancy in a carrier of homozygous type II (L99F) antithrombin deficiency.

J. Corral, J. Díez-Martín, C. Muñoz, 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide

J. Anguita, J. Díez-Martín, M. Kwon, 2020 .

Transjugular Intrahepatic Portosystemic Shunt (TIPS) For Very Severe Veno-occlusive Disease After Unmanipulated Haploidentical HSCT With Post-transplantation Cyclophosphamide.

J. Anguita, J. Díez-Martín, M. Kwon, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Inolimomab in Steroid-Refractory Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis and Comparison with Other Interleukin-2 Receptor Antibodies

A. Fischer, A. Stamatoullas, I. Yakoub-Agha, 2005, Transplantation.

Allogeneic stem cell transplantation in HIV-1 infected patients with high-risk hematological disorders.

J. Anguita, J. Sanz, J. Díez-Martín, 2019, AIDS.

Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation.

P. Bartolomeo, M. Robin, I. Yakoub-Agha, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT

H. Einsele, J. Johansson, W. Wiktor-Jedrzejczak, 2022, Bone Marrow Transplantation.

Allogeneic haematopoietic cell transplantation for extranodal natural killer/T‐cell lymphoma, nasal type: a CIBMTR analysis

Sonali M. Smith, M. Perales, E. Jacobsen, 2018, British journal of haematology.

Evolution of the role of haploidentical stem cell transplantation: past, present, and future

J. Díez-Martín, M. Kwon, R. Bailén, 2020, Expert review of hematology.

Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT

N. Kröger, M. Labopin, A. Nagler, 2021, Journal of Hematology & Oncology.

Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT

M. Labopin, D. Blaise, A. Nagler, 2020, Journal of Hematology & Oncology.

Factors predicting peripheral blood progenitor cell mobilization in healthy donors in the era of related alternative donors: Experience from a single center

J. Anguita, J. Díez-Martín, P. Balsalobre, 2019, Journal of clinical apheresis.

A retrospective cohort of invasive fusariosis in the era of antimould prophylaxis.

C. Rodriguez-Gonzalez, P. Escribano, M. Martínez-Jiménez, 2020, Medical mycology.

Graft-versus-tumor effect after allogeneic stem cell transplantation in HIV-positive patients with high-risk hematologic malignancies.

I. Buño, J. Anguita, J. Berenguer, 2013, AIDS research and human retroviruses.

Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia

M. Labopin, D. Blaise, A. Nagler, 2020, Leukemia.

[GESIDA/PETHEMA guidelines for the diagnosis and treatment of lymphomas in HIV-infected patients].

Jesús Santos, J. Berenguer, J. Díez-Martín, 2002, Medicina clinica.

Chromosome studies in 104 patients with polycythemia vera.

G. Dewald, D. Graham, J. Díez-Martín, 1991, Mayo Clinic proceedings.

Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia.

J. Marin, O. Briz, J. Díez-Martín, 2016, Blood reviews.

Next Generation Cytogenetics in Myeloid Hematological Neoplasms: Detection of CNVs and Translocations

I. Buño, S. Lois, M. Ballesteros, 2021, Cancers.

Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition

I. Buño, P. Font, J. Díez-Martín, 2021, Molecular oncology.

GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus.

J. Menárguez, S. Villà, J. Navarro, 2018, Medicina clinica.

HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation.

I. Buño, J. Ribera, J. Berenguer, 2005, Experimental hematology.

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study

J. Díez-Martín, L. Núñez, A. Jiménez-Ubieto, 2021, HemaSphere.

Flow cytometric analysis of decay‐accelerating factor (CD55) on neutrophils from aplastic anaemia patients

J. Díez-Martín, R. Forés, M. Fernández, 1995, British journal of haematology.

DEVELOPMENT OF ANTI‐BOVINE THROMBIN ANTIBODIES FOLLOWING NEUROSURGICAL PROCEDURES

D. Fass, J. Díez-Martín, R. Sikkink, 1990, British journal of haematology.

Single umbilical cord blood with or without CD34+ cells from a third-party donor in adults with leukemia.

I. Buño, C. Solano, M. Sanz, 2017, Blood advances.

Impact of the addition of antithymocyte globulin to post-transplant cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplant cyclophosphamide alone in acute myeloid leukemia: a retrospective study on behalf of the Acute Leukemia Working Party of the EBMT.

M. Labopin, P. Chevallier, D. Blaise, 2022, Transplantation and cellular therapy.

Retrospective multicenter study of extracorporeal photopheresis in steroid-refractory acute and chronic graft-versus-host disease.

J. Díez-Martín, M. Lozano, M. Kwon, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant

J. Anguita, A. Balas, J. Vicario, 2021, Frontiers in Immunology.

Short Tandem Repeats (STRs) as Biomarkers for the Quantitative Follow-Up of Chimerism after Stem Cell Transplantation: Methodological Considerations and Clinical Application

I. Buño, J. Díez-Martín, C. Martínez-Laperche, 2020, Genes.

Achievement of early complete donor chimerism in CD25+-activated leukocytes is a strong predictor of the development of graft-versus-host-disease after stem cell transplantation.

I. Buño, J. Anguita, J. Díez-Martín, 2015, Experimental hematology.

Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide

I. Buño, J. Anguita, J. Menárguez, 2021, Frontiers in Immunology.

Cytokine Release Syndrome after Allogeneic Stem Cell Transplantation with Post Transplant Cyclophosphamide

J. Anguita, J. Díez-Martín, C. Martínez-Laperche, 2018, Blood.

Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT

D. Blaise, A. Nagler, M. Mohty, 2018, Bone Marrow Transplantation.

Outcome of T‐cell–replete haploidentical stem cell transplantation improves with time in adults with acute lymphoblastic leukemia: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

P. Chiusolo, M. Labopin, A. Nagler, 2021, Cancer.

Allogeneic CD34‐selected stem cell boost as salvage treatment of life‐threatening infection and severe cytopenias after CAR‐T cell therapy

I. Buño, J. Anguita, J. Díez-Martín, 2022, Transfusion.

Transient hemolysis due to anti‐D and anti‐A1 produced by engrafted donor's lymphocytes after allogeneic unmanipulated haploidentical hematopoietic stem cell transplantation

I. Buño, J. Anguita, J. Díez-Martín, 2017, Transfusion.

Mononuclear cell collection for extracorporeal photopheresis by using the “off‐line” system: A comparative study between COBE Spectra and Spectra Optia devices

J. Anguita, J. Díez-Martín, M. Kwon, 2018, Journal of clinical apheresis.

Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing

I. Buño, J. Díez-Martín, C. Martínez-Laperche, 2023, Cancers.

Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant

B. Clotet, J. Martinez-Picado, A. Wensing, 2018, Annals of Internal Medicine.

Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant

M. Labopin, D. Blaise, A. Nagler, 2017, Haematologica.

Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation

I. Buño, J. Anguita, J. Díez-Martín, 2022, Frontiers in Immunology.

Stem cell mobilization in HIV seropositive patients with lymphoma

S. Montoto, C. Almici, U. Tirelli, 2013, Haematologica.

Aplastic anaemia and cvanamide

J. Díez-Martín, E. Ríos-Herranz, D. López-Lacomba, 1992, European journal of haematology.

Donor Cell-Derived Hematologic Neoplasms after Hematopoietic Stem Cell Transplantation: A Systematic Review.

I. Buño, J. Díez-Martín, C. Martínez-Laperche, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Whole-exome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesis

M. Piris, I. Buño, J. Triviño, 2018, Leukemia.

Apparent cure of Graves‐Basedow disease after sibling allogeneic bone marrow transplantation

J. Díez-Martín, B. Barceló, Montserrat Briz, 1999, Clinical endocrinology.

Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms

I. Buño, M. Ballesteros, J. Anguita, 2019, Cancers.

Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms

I. Buño, P. Catalán, J. Triviño, 2022, Annals of Hematology.

Restriction endonuclease in situ digestion (REISD) and fluorescence in situ hybridization (FISH) as complementary methods to analyze chimerism and residual disease after bone marrow transplantation.

I. Buño, P. Llamas, J. Díez-Martín, 1996, Cancer genetics and cytogenetics.

Cell-Free DNA dynamic concentration and other variables are predictors of early progression after CAR T-Cell therapy in DLBCL patients.: cfDNA dynamics pre CAR-T in DLBCL.

I. Buño, J. Díez-Martín, F. Díaz-Crespo, 2023, Transplantation and cellular therapy.

Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin’s lymphoma

I. Buño, L. Sanz, J. Díez-Martín, 2021, Scientific Reports.

Autologous stem-cell transplantation in patients with HIV-related lymphoma.

P. Biron, G. Guillerm, A. Rosselet, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single Cord Blood Transplantation Combined With An HLA Mismatched Third Party Donor For High-Risk Hematological Patients With HIV Infection

I. Buño, P. Ellerbroek, A. Wensing, 2013 .

Vulnerability to reservoir reseeding due to high immune activation after allogeneic hematopoietic stem cell transplantation in individuals with HIV-1

N. Kröger, J. Martinez-Picado, J. van Lunzen, 2020, Science Translational Medicine.

Immune Reconstitution Impact on Overall Survival after Hematopoietic Haploidentical Stem Cell Transplantation

J. Anguita, J. Churruca, J. Díez-Martín, 2016 .

C. Solano, M. Sanz, J. Sanz, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel

I. Buño, J. Anguita, J. Díez-Martín, 2022, Clinical case reports.

R. Fanin, F. Baron, M. Labopin, 2022, American journal of hematology.

Short communication: Immune reconstitution after autologous peripheral blood stem cell transplantation in HIV-infected patients: might be better than expected?

M. Muñoz-Fernández, S. Resino, J. Berenguer, 2007, AIDS research and human retroviruses.

Childbearing age patients with essential thrombocythemia: Should they be placed on interferon?

J. Díez-Martín, M. Fernández, Jose L. Díez‐Martín, 1996, American journal of hematology.

Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report.

N. Kröger, P. Hari, D. Blaise, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts

M. Ballesteros, P. Font, J. Bellón, 2015, Annals of Hematology.

Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT

M. Labopin, D. Blaise, A. Nagler, 2021, Bone Marrow Transplantation.

Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology

M. González-Díaz, I. Buño, E. Barragán, 2018, British journal of haematology.

Post-transplant lymphoproliferative disorder mimicking a thrombotic microangiopathy.

I. Buño, J. Díez-Martín, P. Balsalobre, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of Covid-19 in adult patients with hematologycal malignancies: report of the Covid-19 registry of the madrid society of haematology (AMHH)

J. Martínez-López, J. Díez-Martín, J. García‐Suárez, 2020 .

Post-Transplant Cyclophosphamide after Matched Sibling, Unrelated and Haploidentical Donor Transplants in Patients with Acute Myeloid Leukemia, a Comparative Study of the ALWP EBMT

D. Blaise, A. Nagler, M. Mohty, 2019, Blood.

Dynamics of Sau3A in situ digestion of human chromosomes analyzed with computerized imaging.

I. Buño, J. Díez-Martín, C. López‐Fernández, 1997, Genome.

Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia—a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

P. Galieni, M. Labopin, A. Nagler, 2023, Bone Marrow Transplantation.

Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide

I. Buño, J. Anguita, J. Díez-Martín, 2023, Annals of Hematology.

Patients with Acute Myeloid Leukemia on Non-Intensive Therapy: Applicability of the European Leukemia Net Risk Classification

I. Buño, M. Ballesteros, J. Anguita, 2021, Blood.

Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma

I. Buño, E. Salas, J. Soria, 2021, Cancer medicine.

Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMT

A. Nagler, L. Ruggeri, A. Velardi, 2021, Bone Marrow Transplantation.

Clinical grade production of IL‐15 stimulated NK cells for early infusion in adult AML patients undergoing haploidentical stem cell transplantation with post‐transplant cyclophosphamide

J. Anguita, M. Fernández-Santos, A. Pérez‐Martínez, 2022, Transfusion.

COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study

V. Jiménez‐Yuste, P. Llamas, C. Lumbreras, 2023, Cancers.

Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide

I. Buño, J. Anguita, J. Díez-Martín, 2021, Frontiers in Immunology.

Plasma exchange as an effective salvage therapy in AZD1222 vaccine-induced thrombotic thrombocytopenia: a case report.

F. Anaya, A. Gil-Núñez, J. Díez-Martín, 2021, Blood transfusion = Trasfusione del sangue.

Successful Treatment of Severe Aspergillosis with Isavuconazole Therapy after Allogeneic Stem Cell Transplantation

I. Buño, J. Anguita, J. Guinea, 2019, Chemotherapy.

Genetic biomarkers identify a subgroup of high-risk patients within low-risk NPM1-mutated acute myeloid leukemia

I. Buño, J. Anguita, J. Díez-Martín, 2020, Leukemia & lymphoma.

Methotrexate-Induced Subacute Neurotoxicity Surrounding an Ommaya Reservoir in a Patient with Lymphoma

J. Churruca, J. Guzmán-De-Villoria, J. Díez-Martín, 2019, The American journal of case reports.

Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel

I. Buño, J. Anguita, J. Díez-Martín, 2021, Clinical case reports.

Listeria monocytogenes meningitis in two allogeneic hematopoietic stem cell transplant recipients

I. Buño, C. Castellares, C. Radice, 2006, Leukemia & lymphoma.

Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working Party

N. Russell, P. Dreger, N. Ifrah, 2015, Bone Marrow Transplantation.

PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL.

S. Montoto, D. Blaise, P. Dreger, 2019, Blood advances.

Are myeloma patients with renal failure candidates for autologous stem cell transplantation?

C. Solano, J. Maldonado, J. S. San Miguel, 2000, The hematology journal : the official journal of the European Haematology Association.

A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients

J. Díez-Martín, G. Pérez‐Rus, Maite Chasco-Ganuza, 2021, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

The Outcome of Haplo-Identical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report

P. Hari, D. Blaise, P. Dreger, 2019 .

Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategy

M. Hallek, S. Tuve, A. Kiani, 2011, Leukemia.

Early and Favourable Immune Reconstitution After Unmanipulated Haploidentical Stem Cell Transplantation With High Dose Post-Transplant Cyclophosphamide Regardless Intensity Of Conditioning Regimen

I. Buño, J. Anguita, E. Sarmiento, 2013 .

Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: a report from the EBMT acute leukemia working party.

M. Labopin, D. Blaise, A. Nagler, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant

R. Martino, J. Miguel, Á. Urbano-Ispizua, 2002, Bone Marrow Transplantation.